Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.
Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein.
Multifocal VEP assessment of optic neuritis evolution.
Difference in Motor Fatigue between Patients with Stroke and Patients with Multiple Sclerosis: A Pilot Study.
Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use.
Placebo and nocebo effects in the neurological practice.
Multiple sclerosis (MS) for the urologist: What should urologists know about MS?
Alemtuzumab in multiple sclerosis: an update.
Parent-of-Origin Effects Implicate Epigenetic Regulation of Experimental Autoimmune Encephalomyelitis and Identify Imprinted Dlk1 as a Novel Risk Gene.
Cognitive and Clinical Dysfunction, Altered MEG Resting-State Networks and Thalamic Atrophy in Multiple Sclerosis.
PRISM: A Novel Research Tool to Assess the Prevalence of Pseudobulbar Affect Symptoms across Neurological Conditions.
Multifocal visual evoked potential in optic neuritis, ischemic optic neuropathy and compressive optic neuropathy.
FTY720 for cancer therapy (Review).
Exogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelination.
Disclosure of diagnosis of multiple sclerosis in the workplace positively affects employment status and job tenure.
Botulinum neurotoxin-A treatment of lower urinary tract symptoms in multiple sclerosis.
Indices of Cognitive Dysfunction in Relapsing-Remitting Multiple Sclerosis: Intra-individual Variability, Processing Speed, and Attention Network Efficiency.
Neural drive increases following resistance training in patients with multiple sclerosis.
Effectiveness of psychologically focused group interventions for Multiple Sclerosis: A review of the experimental literature.
Understanding hope in patients with Multiple Sclerosis.
Identification and Preclinical Pharmacology of BMS-986104: A Differentiated S1P1 Receptor Modulator in Clinical Trials.
Adult-Onset Leukoencephalopathies.
Technical developments of functional electrical stimulation to correct drop foot: Sensing, actuation and control strategies.
A Model of Population and Subject (MOPS) Intensities with Application to Multiple Sclerosis Lesion Segmentation.
Magnetization transfer ratio does not correlate to myelin content in the brain in the MOG-EAE mouse model.

Pages